Matthew Strobeck - Dec 30, 2021 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Matthew Strobeck
Stock symbol
BDSX
Transactions as of
Dec 30, 2021
Transactions value $
$642,930
Form type
4
Date filed
1/4/2022, 04:02 PM
Previous filing
Dec 10, 2021
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Purchase $603K +139K +191.31% $4.35 211K Dec 30, 2021 By Birchview Fund LLC F1
transaction BDSX Common Stock Purchase $39.6K +9.1K +84% $4.35 19.9K Dec 30, 2021 By Birchview Capital Separately Managed Account F1
holding BDSX Common Stock 967K Dec 30, 2021 Direct F4
holding BDSX Common Stock 3.52K Dec 30, 2021 By UGMA Account F2, F5
holding BDSX Common Stock 3.52K Dec 30, 2021 By UGMA Account F2, F5
holding BDSX Common Stock 3.52K Dec 30, 2021 By UGMA Account F2, F5
holding BDSX Common Stock 3.52K Dec 30, 2021 By UGMA Account F2, F5
holding BDSX Common Stock 40.7K Dec 30, 2021 By Clajer Capital LLC F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F2 The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 The reporting person is an affiliate of Clajer Capital LLC. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 In the Form 4 filed by the reporting person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned reported in Table I as directly held was inadvertently overstated by 92 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned directly by the reporting person.
F5 In the Form 4 filed by the reporting person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned reported in Table I as held by each UGMA Account was inadvertently overstated by 4 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by each UGMA Account.
F6 In the Form 4 filed by the reporting person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned reported in Table I as held by Clajer Capital LLC was inadvertently overstated by 22 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by Clajer Capital LLC.